Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
PubMed Similar studies GEO Profiles Analyze DataSet
The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia
PubMed Similar studies Analyze with GEO2R
Thalidomide Exerts Distinct Molecular Antileukemic Effects
Stable and Progressive B-CLL
B-cell chronic lymphocytic leukemia progression
Sequential gene expression profiling in CLL during treatment
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy effect on chronic lymphocytic leukemia
An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on